AB
CLVS

Amalgamated Bank’s Clovis Oncology, Inc. CLVS Stock Holding History

Amalgamated Bank’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,424
Closed -$37K – 3305
2022
Q1 		$37K Sell
18,424
-1,419
-7% -$2.79K ﹤0.01% 2611
2021
Q4 		$54K Sell
19,843
-193
-1% -$713 ﹤0.01% 2108
2021
Q3 		$89K Buy
20,036
+1,225
+7% +$5.9K ﹤0.01% 2092
2021
Q2 		$109K Buy
18,811
+7,009
+59% +$41.1K ﹤0.01% 2113
2021
Q1 		$83K Sell
11,802
-1,174
-9% -$7.87K ﹤0.01% 1561
2020
Q4 		$62K Buy
12,976
+58
+0.4% +$293 ﹤0.01% 1554
2020
Q3 		$75K Buy
12,918
+1,396
+12% +$8.35K ﹤0.01% 1433
2020
Q2 		$78K Buy
+11,522
New +$87.2K ﹤0.01% 1423
2018
Q3 		– Sell
-7,283
Closed -$331K – 1657
2018
Q2 		$331K Buy
7,283
+1,406
+24% +$68.4K 0.01% 1263
2018
Q1 		$310K Sell
5,877
-104
-2% -$6.07K 0.01% 1198
2017
Q4 		$407K Buy
5,981
+394
+7% +$27.5K 0.01% 1101
2017
Q3 		$460K Buy
5,587
+776
+16% +$61.5K 0.01% 986
2017
Q2 		$450K Buy
4,811
+454
+10% +$27.8K 0.01% 1004
2017
Q1 		$277K Buy
+4,357
New +$265K 0.01% 1182
2015
Q4 		– Sell
-2,915
Closed -$268K – 1280
2015
Q3 		$268K Buy
2,915
+342
+13% +$29.6K 0.03% 958
2015
Q2 		$226K Buy
+2,573
New +$220K 0.02% 1173

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Amalgamated Bank's CLVS Position: Q2 2022 in Review

Amalgamated Bank sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 18,424 shares — an estimated $37K sold.

Amalgamated Bank first reported a position in CLVS in Q2 2015 and held it in 16 quarters. The position peaked at $460K in Q3 2017. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • Amalgamated Bank reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 18,424 Clovis Oncology, Inc. shares in Q2 2022, an estimated $37K.
  • Amalgamated Bank first reported a position in Clovis Oncology, Inc. in Q2 2015 and held it in 16 quarters.
  • Amalgamated Bank's Clovis Oncology, Inc. position peaked at $460K in Q3 2017.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.